An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety ofTabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases

Project: Research project

Project Details

Description

An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects with Epstein-Barr Virus-associated Diseases
StatusActive
Effective start/end date4/20/214/30/26

Funding

  • ATARA BIOTHERAPEUTICS, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.